Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/22914
Title: | Anti-mycobacterial activity of a bis-sulfonamide | Contributor(s): | Wilkinson, Brendan (author)![]() |
Publication Date: | 2007 | DOI: | 10.1016/j.bmcl.2006.11.079 | Handle Link: | https://hdl.handle.net/1959.11/22914 | Abstract: | A bis-arylsulfonamide, 7, has been identified that exhibits growth inhibition of Mycobacterium smegmatis at less than 25 μg/mL, but has no such activity against Escherichia coli or Staphylococcus aureus. A closely related bis-arylsulfonamide (8) was much less active, but was the only other compound among 54 arylsulfonamides tested with detectable growth inhibition of M. smegmatis. | Publication Type: | Journal Article | Source of Publication: | Bioorganic & Medicinal Chemistry Letters, 17(5), p. 1355-1357 | Publisher: | Pergamon Press | Place of Publication: | United Kingdom | ISSN: | 1464-3405 0960-894X |
Fields of Research (FoR) 2008: | 030499 Medicinal and Biomolecular Chemistry not elsewhere classified 030503 Organic Chemical Synthesis 030401 Biologically Active Molecules |
Fields of Research (FoR) 2020: | 340499 Medicinal and biomolecular chemistry not elsewhere classified 340401 Biologically active molecules 340503 Organic chemical synthesis |
Socio-Economic Objective (SEO) 2008: | 970103 Expanding Knowledge in the Chemical Sciences 970106 Expanding Knowledge in the Biological Sciences 929999 Health not elsewhere classified |
Socio-Economic Objective (SEO) 2020: | 280102 Expanding knowledge in the biological sciences 280105 Expanding knowledge in the chemical sciences 200199 Clinical health not elsewhere classified |
Peer Reviewed: | Yes | HERDC Category Description: | C1 Refereed Article in a Scholarly Journal |
---|---|
Appears in Collections: | Journal Article School of Science and Technology |
Files in This Item:
File | Description | Size | Format |
---|
SCOPUSTM
Citations
34
checked on Jul 20, 2024
Page view(s)
1,518
checked on Mar 3, 2024
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.